Stock Market Today: Nasdaq Skyrockets After Meta Earnings, Buyback News
The Dow, on the other hand, closed lower on disappointing guidance from Merck (MRK).
Most stocks jumped out of the gate Thursday, as optimism spilled over from Wednesday's Fed meeting, where the central bank issued its smallest interest rate hike since March 2022.
Solid guidance and big buyback news from Facebook parent Meta Platforms (META) – not to mention one of the best days ever for its stock – gave the risk-on rally some legs. The buying power wasn't widespread, though, as an earnings-induced selloff in drugmaker Merck (MRK) kept the blue-chip Dow Jones Industrial Average in check.
The major benchmarks swung higher late Tuesday after the Federal Reserve raised its benchmark interest rate by 25 basis points (0.25%). This followed a 0.50% hike in December and four straight 0.75% increases prior to that. Meanwhile, Fed Chair Jerome Powell said in a mid-afternoon press conference that the central bank will stay the course in its fight against inflation. Still, markets are actually pricing in rate cuts later this year, according to CME Group.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
On the earnings front, Meta Platforms said fourth-quarter earnings fell 52% year-over-year to $1.76 per share, missing analysts' consensus estimate. Revenue also declined in the three-month period, to $33.7 billion, though this was higher than expected. The company said it expects operating expenses and capital expenditures to be lower this year due to several cost-cutting measures, including layoffs it announced late last year. Meta also unveiled a new $40 billion stock buyback program. In reaction, META stock surged 23.3% – its biggest one-day gain since 2013.
At the close, the Nasdaq Composite was up 3.3% at 12,200, and the S&P 500 was 1.5% higher at 4,179. The Dow, on the other hand, finished down 0.1% at 34,053 as MRK slid 3.3% after the company gave lower-than-expected 2023 guidance due to falling COVID-19 vaccine sales.
The Best Recession-Proof Stocks
Recent stock market price action has been a welcome relief for investors following a turbulent 2022. Still, many market participants remain bearish early on in 2023, according to the results of Morgan Stanley's individual investor pulse survey. The majority of respondents (55%) listed inflation as the top risk to their portfolios, followed by recession risk (49%) and market volatility (44%).
"It's been a challenging market environment as investors navigate through high inflation, geopolitical concerns and recession fears," says Mike Loewengart, head of model portfolio construction at Morgan Stanley. "While these challenges aren't likely to disperse anytime soon, it's important for investors, where appropriate, to remain committed to their plan and consider the diversification of their portfolio. Moving money to the sidelines may sound tempting, but for investors with a lengthier time horizon, staying the course may be beneficial in the long run."
Fortunately for investors, there are solid portfolio choices they can make to help maneuver potential upcoming market challenges. These include choosing the best dividend stocks, as well as the best stocks for rising interest rates. There's also this list of top recession-proof stocks, which include high-quality companies that are well-positioned to traverse an economic downturn.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Earnings Season: Live Updates and Commentary
Fourth-quarter earnings season is getting underway, and Wall Street is keeping a close eye on both results and guidance.
By Kiplinger Staff Last updated
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Stock Market Today: Dow Slides 697 Points on Super-Hot Jobs Data
When the December nonfarm payrolls report hit the tape, there was no question which way stocks would go at Friday's opening bell.
By David Dittman Published
-
Blowout December Jobs Report Puts Rate Cuts on Ice: What the Experts Are Saying
Jobs Report The strongest surge in hiring since March keeps the Fed on hold for now.
By Dan Burrows Published
-
Stock Market Today: Stocks End Mixed After FOMC Minutes
The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
By Karee Venema Published
-
Stock Market Today: Stocks Dragged Down by Strong Data
Investors weigh the prospect of no more rate cuts in the current cycle.
By David Dittman Published
-
Meta Adds Dana White to Its Board, Ends Fact-Checking: What to Know
Meta stock is lower Tuesday after the Facebook parent said it is adding UFC CEO Dana White to its board of directors and ending fact-checking on its platforms.
By Joey Solitro Published
-
Stock Market Today: Tech Stocks Soar Ahead of CES 2025
This week's annual technology event will give updates on AI, EVs and self-driving cars.
By Karee Venema Published
-
Stock Market Today: Dow Adds 340 Points to End Skid
The S&P 500 closed the official Santa Claus rally period down 0.5%.
By David Dittman Published